best glp-1 for type 2 diabetes receptor agonists GLP-1-based therapies for diabetes, obesity

TB-500 is a synthetic peptide fragment of thymosin beta-4 that promotes actin regulation and cellular motility, particularly in sites of trauma

Articles which did not meet inclusion criteria were excluded

This phenomenon may help explain the obesity paradox, which suggests that, even though people who are obese are at greater risk of developing heart issues, once heart disease develops, individuals with higher BMIs appear to have a lower mortality risk than people with normal BMIs

Ongoing research continues to refine our understanding of this potential complication, and clinicians should remain vigilant for emerging safety data while balancing the substantial metabolic benefits these medications provide for appropriate patients